Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions-Reference-Cited by-同舟云学术

Glycyrrhizin inhibits the manifestations of anti-inflammatory responses that appear in association with systemic inflammatory response syndrome (SIRS)-like reactions

Published:2006-09 Issue:5-6 Volume:35 Page:295-301
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Takei Miwa,Kobayashi Makiko,Herndon David N.,Pollard Richard B.,Suzuki Fujio

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference40 articles.

1. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis;Bone;Chest,1992

2. Inflammatory cell activation in sepsis;Bellingan;Br Med Bull,1999

3. Immunological dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS);Bone;Ann Intern Med,1996

4. Systemic inflammatory response syndrome: a unifying concept of systemic inflammation;Bone,1997

5. Systemic responses to trauma;Foex;Br Med Bull,1999

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural sweetener glycyrrhizin protects against precocious puberty by modulating the gut microbiome;Life Sciences;2024-08

2. In Vitro Biological Activities and Relative Chemicals in Different Extracts of Licorice and Fermenting Licorice;Asian Journal of Beauty and Cosmetology;2024-06-30

3. Analysis of the network pharmacology and the structure-activity relationship of glycyrrhizic acid and glycyrrhetinic acid;Frontiers in Pharmacology;2022-10-13

4. Blood cell-based drug delivery systems: A biomimetic platform for antibacterial therapy;European Journal of Pharmaceutics and Biopharmaceutics;2022-08

5. Exploring the Pharmacological Potential of Glycyrrhizic Acid: From Therapeutic Applications to Trends in Nanomedicine;Future Pharmacology;2022-01-04